666

JIANGSU LIANHUAN PHARMACEUTICAL

No trades
See on Supercharts
Market capitalization
‪2.42 B‬CNY
‪135.01 M‬CNY
‪2.15 B‬CNY
‪274.02 M‬
Beta (1Y)
1.25

About JIANGSU LIANHUAN PHARMACEUTICAL

CEO
Ben Niu
Headquarters
Yangzhou
Employees (FY)
‪1.3 K‬
Founded
1958
ISIN
CNE000001DP6
FIGI
BBG000CNZF67
Jiangsu Lianhuan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and sale of chemicals and pharmaceutical products. It offers chemical synthetic drugs, antibiotics, and various preparations and auxiliary raw materials for medical use. The company was founded in 1958 and is headquartered in Yangzhou, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 600513 is 8.67 CNY — it has increased by 1.29% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange JIANGSU LIANHUAN PHARMACEUTICAL stocks are traded under the ticker 600513.
600513 stock is 2.00% volatile and has beta coefficient of 1.25. Check out the list of the most volatile stocks — is JIANGSU LIANHUAN PHARMACEUTICAL there?
Yes, you can track JIANGSU LIANHUAN PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
600513 stock has risen by 5.86% compared to the previous week, the month change is a 5.35% fall, over the last year JIANGSU LIANHUAN PHARMACEUTICAL has showed a 20.31% decrease.
600513 net income for the last quarter is ‪46.17 M‬ CNY, while the quarter before that showed ‪27.31 M‬ CNY of net income which accounts for 69.02% change. Track more JIANGSU LIANHUAN PHARMACEUTICAL financial stats to get the full picture.
Today JIANGSU LIANHUAN PHARMACEUTICAL has the market capitalization of ‪2.44 B‬, it has increased by 4.57% over the last week.
Yes, 600513 dividends are paid annually. The last dividend per share was 0.15 CNY. As of today, Dividend Yield (TTM)% is 1.75%. Tracking JIANGSU LIANHUAN PHARMACEUTICAL dividends might help you take more informed decisions.
JIANGSU LIANHUAN PHARMACEUTICAL dividend yield was 1.35% in 2023, and payout ratio reached 31.71%. The year before the numbers were 1.60% and 30.29% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 600513 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JIANGSU LIANHUAN PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
600513 reached its all-time high on Jun 12, 2015 with the price of 24.75 CNY, and its all-time low was 1.10 CNY and was reached on Mar 21, 2006.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has ‪1.30 K‬ employees. See our rating of the largest employees — is JIANGSU LIANHUAN PHARMACEUTICAL on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JIANGSU LIANHUAN PHARMACEUTICAL technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JIANGSU LIANHUAN PHARMACEUTICAL stock shows the sell signal. See more of JIANGSU LIANHUAN PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JIANGSU LIANHUAN PHARMACEUTICAL EBITDA is ‪235.09 M‬ CNY, and current EBITDA margin is 10.91%. See more stats in JIANGSU LIANHUAN PHARMACEUTICAL financial statements.